Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 149 Breast Neoplasms 87 Colorectal Neoplasms 64 Neoplasms 53 Pancreatic Neoplasms 52 Lung Neoplasms 49 Neoplasm Metastasis 45 Stomach Neoplasms 43 Ovarian Neoplasms 42 Rectal Neoplasms 41 Esophageal Squamous Cell Carcinoma 34 Esophageal Neoplasms 33 Squamous Cell Carcinoma of Head and Neck 30 Head and Neck Neoplasms 30 Leukemia, Myeloid, Acute 28 Recurrence 24 Triple Negative Breast Neoplasms 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Glioblastoma 21 Uterine Cervical Neoplasms 20 Small Cell Lung Carcinoma 20 Nasopharyngeal Carcinoma 20 Fallopian Tube Neoplasms 19 Lymphoma, Non-Hodgkin 18 Lymphoma 18 Colonic Neoplasms 17 Prostatic Neoplasms 16 Leukemia 15 Carcinoma, Ovarian Epithelial 15 Melanoma 14

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HER2 Negative Breast Cancer × Drug Therapy × Clear all

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡